Concepedia

Takeaki Miyata

TM

Statistics

Publications

5

Citations

96

H-Index

5

Active since

2015

Affiliations

Hyogo Medical University(Current)

Uji Hospital

Takeaki Miyata is an author at Hyogo Medical University specializing in tumor biology, oncology, and medicine.

ORCID

Top concepts

Publications per year

2015–2022

5

Publications

5

The Clinical Significance of Cancer Stem Cell Markers ALDH1A1 and CD133 in Lung Adenocarcinoma

Takeaki Miyata, Tsunehiro Oyama, Takashi Yoshimatsu et al. · Anticancer Research · 2017 · 35 citations · Full text

Cancer stem cell markers in lung cancer

Takeaki Miyata, Takashi Yoshimatsu, Tetsuya So et al. · Personalized Medicine Universe · 2015 · 20 citations

Triple-negative expression (ALDH1A1-/CD133-/mutant p53-) cases in lung adenocarcinoma had a good prognosis

Naoki Yamashita, Tetsuya So, Takeaki Miyata et al. · Scientific Reports · 2022 · 16 citations · Full text

, , +14

Piperazine-based Alpha-1 AR Blocker, Naftopidil, Selectively Suppresses Malignant Human Bladder Cells via Induction of Apoptosis.

Yusuke U. Nakagawa, Hisao Nagaya, Takeaki Miyata et al. · PubMed · 2016 · 14 citations

, , +12

Association Between CD133 Expression and Prognosis in Human Lung Adenocarcinoma

Naoki Yamashita, Tsunehiro Oyama, Tetsuya So et al. · Anticancer Research · 2021 · 11 citations · Full text

1–5 of 5